FITB heads into May with short sellers pulling back sharply — just as the Street responds positively to a solid Q1 print.
Shorts have been unwinding with conviction. Short interest in Fifth Third has dropped 8.2% over the past week to 5.85% of the free float, the clearest sign yet that the bearish thesis is fading after peaking near 7% of float in early April. The retreat is steady — positions have come off from roughly 47 million shares in early April to just under 39 million now. The lending market tells the same story of loosening pressure: with availability well above squeeze territory and borrow costs at a modest 0.48% — a 30-day range that has stayed tight to the half-percent mark — there is no structural friction holding new shorts in place. The ORTEX short score eased further to 39.8, down from above 41 earlier in April, reflecting the gradual unwinding of bearish conviction. Days to cover of nearly six means an aggressive short squeeze remains an unlikely path, but the trend favours the bulls.
Options positioning pushes back slightly against that optimistic read. The put/call ratio has climbed to 0.91, more than two standard deviations above its 20-day mean of 0.81 — the highest defensive skew in recent weeks. That level is still well below the 52-week high of 1.87 set at the peak of last year's regional banking anxiety, but the move is notable for a stock that had been tracking closer to 0.72 in late March. Options traders are buying more downside protection even as short sellers exit — a divergence worth monitoring heading into a quieter summer quarter.
The Street is broadly constructive after Q1 results posted on April 17. Barclays raised its target to $63 (Overweight), Evercore ISI lifted to $53, and JPMorgan — which reinstated coverage in March — bumped its Overweight target to $53 as well. These moves bracket a consensus mean target of $57.30, roughly 15% above the current price of $49.79. The EPS picture adds weight to that optimism: the 12-month forward EPS growth score ranks at the 92nd percentile, and the 30-day EPS momentum score sits at the 69th percentile. That combination of rising forward estimates and improving momentum is a credible foundation for the target-price uplift. The P/E of 11.5 and price-to-book of 1.33 are undemanding for a bank posting this trajectory, and the forward dividend yield of 3.3% provides a floor for income buyers.
The Q1 earnings reaction was muted in practice despite the positive analyst response — the stock gained 2.9% on April 17, then gave most of that back over the following five sessions. That pattern of post-earnings fade is consistent with a broader regional banking group that has struggled to hold breakout moves. Peers HBAN dropped 3% on the week, RF and MTB both fell around 0.7–0.9%, and CFG lost 1.2%. FITB's 1.5% weekly decline broadly tracks its peer group — weakness here looks sector-driven rather than company-specific.
Institutional flows from the latest filings show broad net buying. T. Rowe Price added over 10 million shares in Q1, and BlackRock built a position of similar scale. That level of active inflow from sizeable mandates argues the institutional community is not positioned defensively. Insider activity is less emphatic: an EVP sold roughly $305,000 in shares around April 20, and the Chief Accounting Officer sold a modest parcel on April 17. None of the trades carry high significance scores, and net insider activity over 90 days — which includes earlier CIO sales — still shows net selling of value. Not alarming at these price levels, but no bullish signal either.
The next scheduled earnings event is July 17. Between now and then, the key variable is whether forward EPS estimates hold their recent momentum or begin to moderate as loan-loss and net interest margin assumptions are revised for the second half of the year.
See the live data behind this article on ORTEX.
Open FITB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
